ArticlePharmaceutics2026

CD44 Targeting of Cisplatin-Loaded Hyaluronic Acid-Modified Mesoporous Silica Nanoparticles for Lung Adenocarcinoma: Synthesis, Characterization, In Vitro and In Vivo Evaluation.

Cem Güler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.